Found: 83
Select item for more details and to access through your institution.
Could or Should We Use Cost-Effectiveness Thresholds in the French Value-Based Pricing Process for New Drugs?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 829, doi. 10.1007/s40273-024-01394-8
- By:
- Publication type:
- Article
A Prototype Software Framework for Transferable Computational Health Economic Models and Its Early Application in Youth Mental Health.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 833, doi. 10.1007/s40273-024-01378-8
- By:
- Publication type:
- Article
A Systematic Review of Methods and Practice for Integrating Maternal, Fetal, and Child Health Outcomes, and Family Spillover Effects into Cost-Utility Analyses.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 843, doi. 10.1007/s40273-024-01397-5
- By:
- Publication type:
- Article
A Systematic Review of Methods for Estimating Productivity Losses due to Illness or Caregiving in Low- and Middle-Income Countries.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 865, doi. 10.1007/s40273-024-01402-x
- By:
- Publication type:
- Article
Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 879, doi. 10.1007/s40273-024-01386-8
- By:
- Publication type:
- Article
Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 8, p. 895, doi. 10.1007/s40273-024-01359-x
- By:
- Publication type:
- Article
Correction to: Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists' and Urologists' Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
PharmacoEconomics Supplement: Advancing methods to measure and reward healthcare innovation: results from the valuing innovation project.
- Published in:
- 2024
- Publication type:
- Announcement
Advancing Methods to Measure and Reward Healthcare Innovation.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 187, doi. 10.1007/s40273-024-01396-6
- By:
- Publication type:
- Article
Incorporating Real Option Value in Valuing Innovation: A Way Forward.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 199, doi. 10.1007/s40273-024-01352-4
- By:
- Publication type:
- Article
Estimating and Rewarding the Value of Healthcare Interventions Beyond the Healthcare Sector: A Conceptual Framework.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 211, doi. 10.1007/s40273-024-01392-w
- By:
- Publication type:
- Article
Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 715, doi. 10.1007/s40273-024-01364-0
- By:
- Publication type:
- Article
Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 721, doi. 10.1007/s40273-024-01387-7
- By:
- Publication type:
- Article
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 737, doi. 10.1007/s40273-024-01377-9
- By:
- Publication type:
- Article
Cost-of-Illness of Skin Cancer: A Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 751, doi. 10.1007/s40273-024-01389-5
- By:
- Publication type:
- Article
Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 767, doi. 10.1007/s40273-024-01365-z
- By:
- Publication type:
- Article
Barriers and Facilitators of Using R for Decision Analytic Modeling in Health Technology Assessment: Focus Group Results.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 783, doi. 10.1007/s40273-024-01374-y
- By:
- Publication type:
- Article
A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 797, doi. 10.1007/s40273-024-01376-w
- By:
- Publication type:
- Article
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 7, p. 811, doi. 10.1007/s40273-024-01380-0
- By:
- Publication type:
- Article
PharmacoEconomics Supplement: Advancing measurement of children's health-related quality of life - evidence from the QUOKKA (QUality OF Life in Kids: Key evidence to strengthen decisions in Australia) research program.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 1, doi. 10.1007/s40273-024-01384-w
- Publication type:
- Article
Meeting the Challenges of Preference-Weighted Health-Related Quality-of-Life Measurement in Children.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 3, doi. 10.1007/s40273-024-01383-x
- By:
- Publication type:
- Article
Exploring the Use of Pictorial Approaches in the Development of Paediatric Patient-Reported Outcome Instruments: A Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 9, doi. 10.1007/s40273-024-01357-z
- By:
- Publication type:
- Article
Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 39, doi. 10.1007/s40273-023-01330-2
- By:
- Publication type:
- Article
Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 57, doi. 10.1007/s40273-024-01354-2
- By:
- Publication type:
- Article
Correction: Comparing the Psychometric Performance of Generic Paediatric Health‑Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 79, doi. 10.1007/s40273-024-01373-z
- By:
- Publication type:
- Article
Comparing Generic Paediatric Health-Related Quality-of-Life Instruments: A Dimensionality Assessment Using Factor Analysis.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 81, doi. 10.1007/s40273-024-01382-y
- By:
- Publication type:
- Article
A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 95, doi. 10.1007/s40273-024-01379-7
- By:
- Publication type:
- Article
An Investigation of Inter-Rater and Intra-Proxy Agreement in Measuring Quality of Life of Children in the Community Using the EQ-5D-Y-3L.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 113, doi. 10.1007/s40273-024-01356-0
- By:
- Publication type:
- Article
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 129, doi. 10.1007/s40273-024-01350-6
- By:
- Publication type:
- Article
Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2–4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL).
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 147, doi. 10.1007/s40273-024-01355-1
- By:
- Publication type:
- Article
The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions.
- Published in:
- PharmacoEconomics, 2024, v. 42, p. 163, doi. 10.1007/s40273-024-01351-5
- By:
- Publication type:
- Article
Market Transparency in Medicine Pricing: Pathways to Fair Pricing.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 611, doi. 10.1007/s40273-024-01390-y
- By:
- Publication type:
- Article
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 615, doi. 10.1007/s40273-024-01381-z
- By:
- Publication type:
- Article
Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 619, doi. 10.1007/s40273-024-01370-2
- By:
- Publication type:
- Article
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 633, doi. 10.1007/s40273-024-01375-x
- By:
- Publication type:
- Article
Childhood Transitions Between Weight Status Categories: Evidence from the UK Millennium Cohort Study.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 649, doi. 10.1007/s40273-024-01361-3
- By:
- Publication type:
- Article
Developing a Program Costs Checklist of Digital Health Interventions: A Scoping Review and Empirical Case Study.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 663, doi. 10.1007/s40273-024-01366-y
- By:
- Publication type:
- Article
Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 679, doi. 10.1007/s40273-024-01371-1
- By:
- Publication type:
- Article
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 6, p. 693, doi. 10.1007/s40273-024-01385-9
- By:
- Publication type:
- Article
Economic Evaluations of Treatments for Duchenne Muscular Dystrophy: The Caregiver QALY Trap.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 475, doi. 10.1007/s40273-024-01367-x
- By:
- Publication type:
- Article
Value of Information for Clinical Trial Design: The Importance of Considering All Relevant Comparators.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 479, doi. 10.1007/s40273-024-01372-0
- By:
- Publication type:
- Article
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 487, doi. 10.1007/s40273-024-01363-1
- By:
- Publication type:
- Article
Content Comparison of Quality-of-Life Instruments Used in Economic Evaluations of Sleep Disorder Interventions: A Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 507, doi. 10.1007/s40273-023-01349-5
- By:
- Publication type:
- Article
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 527, doi. 10.1007/s40273-024-01362-2
- By:
- Publication type:
- Article
Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy in the USA.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 569, doi. 10.1007/s40273-024-01358-y
- By:
- Publication type:
- Article
Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 583, doi. 10.1007/s40273-024-01360-4
- By:
- Publication type:
- Article
Comment on: A Framework for the Fair Pricing of Medicines.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 605, doi. 10.1007/s40273-024-01368-w
- By:
- Publication type:
- Article
Reply to Comment on "A Framework for Fair Pricing of Medicines".
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 5, p. 607, doi. 10.1007/s40273-024-01369-9
- By:
- Publication type:
- Article